Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

gía de la compañía, y el impacto de los datos clínicos y otros datos técnicos. Las declaraciones prospectivas se basan en las actuales expectativas de la dirección y están sujetas a riesgos e incertidumbres que pueden causar que los resultados de Volcano difieran material y adversamente de las declaraciones contenidas aquí. Algunos de los posibles riesgos e incertidumbres que podrían causar que los resultados reales difieran incluyen el ritmo y extensión de la adopción de mercado de los productos y tecnologías de la compañía, resultados clínicos no esperados, incluyendo datos clínicos nuevos no esperados y análisis adicionales de datos clínicos existentes, acciones regulatorias no esperadas o retrasos o regulaciones gubernamentales, la capacidad de la compañía para mantener u obtener patentes o protección de la propiedad intelectual, competencia en general, presiones de la industria en general o de precios públicos, temas no previstos de fabricación, estrategias de crecimiento, la oportunidad y logro de hitos de desarrollo de productos, el resultado de litigios, el impacto y beneficios del desarrollo de mercado, introducciones de productos, nuevos datos no esperados, problemas de seguridad y técnicos, las condiciones del mercado y otros riesgos inherentes al desarrollo y comercialización de dispositivos médicos. Estos y otros riesgos e incertidumbres se describen totalmente en los archivos de Volcano presentados a la Comisión de Bolsa y Valores, incluyendo nuestro informe trimestral reciente en Formulario 10-Q. No debería depositarse una confianza indebida en las declaraciones prospectivas que se refieren solo a la fecha en que se realizaron. Volcano no asume obligación alguna de actualizar las declaraciones prospectivas para reflejar nueva información, eventos o circunstancias después de la fecha en que se r
'/>"/>
SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Codman Neuro*, part of DePuy Synthes Companies of ... embolic coils for the treatment of brain aneurysms, supported ... stability and provide an optimized detachment zone for coils ... Society of NeuroInterventional Surgery (SNIS) 12 th Annual ... finishing coils used during a minimally invasive endovascular procedure ...
(Date:7/28/2015)... Amgen (NASDAQ: AMGN ) announced that ... share dividend for the third quarter of 2015. The ... all stockholders of record as of the close of ... Amgen Amgen is committed to unlocking the potential of ... developing, manufacturing and delivering innovative human therapeutics. This approach ...
(Date:7/28/2015)... BILLERICA, Mass. , July 28, 2015  Insulet ... insulin pump technology with its OmniPod ® Insulin ... has been appointed to Insulet,s Board of Directors. ... of top-tier healthcare experience to the Insulet Board. She ... of the Joslin Diabetes Center, the world,s largest diabetes ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
... Bionovo, Inc. (Nasdaq: BNVI ) announced today that ... fiscal year 2009 ended September 30, 2009 on Thursday, November ... web cast to review the financial results on Thursday, November ... access the call by dialing (800) 860-2442 or (412) 858-4600, ...
... AMSTERDAM, October 29 Amsterdam Molecular,Therapeutics ... entered into a development and commercialization agreement for,LPLchip(TM), a ... lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as,a ... In June of this year AMT ...
Cached Medicine Technology:AMT Starts Development LPLChip(TM) With Progenika 2AMT Starts Development LPLChip(TM) With Progenika 3
(Date:7/29/2015)... ... July 29, 2015 , ... ... entered into a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the ... projects that the companies undertake could improve worker mobility, functionality and fitness levels. ...
(Date:7/29/2015)... Estates, IL (PRWEB) , ... July 29, 2015 , ... ... both benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced ... which can be squeezed into small corners on a porch, balcony, or rooftop – ...
(Date:7/29/2015)... ... 29, 2015 , ... Indiana is known for basketball, the boyhood home of ... Indianapolis, which plans to expand across the state. , Ray Kennedy, owner of the ... in business and we should double our first year’s revenue. More importantly, we ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... seeking funding for a study on the potentially lifesaving impact of removing aluminum ... . , The research proposal is based on a successful pilot study ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth ... in Sarasota to be chosen by the manufacturer to offer and perform ... injectable, non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. ...
Breaking Medicine News(10 mins):Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... was diagnosed with lung cancer has won $ 1 million in ... suffering from an inoperable lung cancer. ,Doctors have given ... At this juncture, he has won this lottery. But the irony ... paid $50,000 in annual installments over twenty years. ,Schenk ...
... University in Chicago claim that men who have undergone ... type// of dementia. This study was published in Cognitive ... on 106 men. Out of this, 25 developed a ... undergone vasectomy. According to the chief scientist of this ...
... new study suggests that patients who develop Parkinson's ... history includes alcohol// abuse may be more likely ... of medications used to treat their condition. ... hypersexuality, binge eating and pathological gambling—have been associated ...
... People who have multiple sclerosis (MS) for 10 years and have ... they// have “benign MS” and that their symptoms will likely not ... A new study shows that unfortunately this may not be correct. ... nearly half of those whose MS was benign at 10 years, ...
... Medicare coverage for colorectal cancer screening has increased, there ... a report published recently, some of these disparities are ... ,Colorectal cancer is the third most common ... with approximately 145,290 new cases in 2005, according to ...
... test that can distinguish between a pair of nearly ... treatment. ,Their report is published this week ... the National Academy of Sciences. ,"This simple ... quickly implemented in the clinic to benefit patients by ...
Cached Medicine News:Health News:Compulsive Gambling Linked to Parkinson's Disease Medications 2Health News:Disparities in Colon Cancer Screening Remain Among Medicare Patients 2Health News:A New Two-gene Test to Discern Similar Gastrointestinal Cancers 2
This is adapted to microplate or card....
ScanGel® Incubator...
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... 120 Mini-Vertical Gel System simplifies the process of ... format. It is able to run four gels ... To maximize utility and throughput, the 120 mini-vertical ... gels (W x L) at one time. The ...
Medicine Products: